Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kerr

Showing results (161-170 of 221) with videos related to

Pageof 23
Sort By:
Anticancer Research|May 1, 1991
Oncogene transfection of mink lung cells: effect on growth characteristics in vitro and in vivoM Z Khan, D A Spandidos, D J Kerr, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2003
A pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solutionK B Hosie, D J Kerr, J A Gilbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracilD J Kerr, J A Ledermann, C S McArdle, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Melphalan concentration and distribution in the tissues of tumour-bearing limbs treated by isolated limb perfusionR N Scott, R Blackie, D J Kerr, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancerD I Jodrell, W Oster, D J Kerr, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A phase I study of regionally administered mitomycin microcapsules for patients with colorectal liver metastasesJ H Anderson, J A Goldberg, J G Eley, et al.
British Journal of Cancer|July 1, 1988
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitorD Veale, J Carmichael, B M Cantwell, et al.
Cancer Research|July 1, 1989
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and miceJ Cummings, J A Double, M C Bibby, et al.
British Journal of Cancer|July 1, 1992
The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanomaR N Scott, D J Kerr, R Blackie, et al.
Clinical Science (London, England : 1979)|June 1, 1987
Circadian variation of thyrotrophin, determined by ultrasensitive immunoradiometric assay, and the effect of low dose nocturnal dopamine infusionD J Kerr, V K Singh, M G McConway, et al.
Pageof 23

Showing results (161-170 of 221) with videos related to

Sort By:
Pageof 23
Anticancer Research|May 1, 1991
Oncogene transfection of mink lung cells: effect on growth characteristics in vitro and in vivoM Z Khan, D A Spandidos, D J Kerr, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2003
A pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solutionK B Hosie, D J Kerr, J A Gilbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracilD J Kerr, J A Ledermann, C S McArdle, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Melphalan concentration and distribution in the tissues of tumour-bearing limbs treated by isolated limb perfusionR N Scott, R Blackie, D J Kerr, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancerD I Jodrell, W Oster, D J Kerr, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A phase I study of regionally administered mitomycin microcapsules for patients with colorectal liver metastasesJ H Anderson, J A Goldberg, J G Eley, et al.
British Journal of Cancer|July 1, 1988
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitorD Veale, J Carmichael, B M Cantwell, et al.
Cancer Research|July 1, 1989
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and miceJ Cummings, J A Double, M C Bibby, et al.
British Journal of Cancer|July 1, 1992
The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanomaR N Scott, D J Kerr, R Blackie, et al.
Clinical Science (London, England : 1979)|June 1, 1987
Circadian variation of thyrotrophin, determined by ultrasensitive immunoradiometric assay, and the effect of low dose nocturnal dopamine infusionD J Kerr, V K Singh, M G McConway, et al.
Pageof 23